Znanstveni rad - Izvorni znanstveni rad
Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market

Mance, Diana; Mance, Davor; Vitezić, Dinko (2016)
Citirajte ovaj rad

Mance, D., Mance, D. i Vitezić, D. (2016). Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market. Croatian medical journal, 57. (6), 582-590. doi: 10.3325/cmj.2016.57.582

Mance, Diana, et al. "Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market." Croatian medical journal, vol. 57, br. 6, 2016, str. 582-590. https://doi.org/10.3325/cmj.2016.57.582

Mance, Diana, Davor Mance i Dinko Vitezić. "Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market." Croatian medical journal 57, br. 6 (2016): 582-590. https://doi.org/10.3325/cmj.2016.57.582

Mance, D., Mance, D. i Vitezić, D. (2016) 'Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market', Croatian medical journal, 57(6), str. 582-590. doi: 10.3325/cmj.2016.57.582

Mance D, Mance D, Vitezić D. Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market. Croatian medical journal [Internet]. 15.12.2016. [pristupljeno 17.10.2019.];57(6):582-590. doi: 10.3325/cmj.2016.57.582

D. Mance, D. Mance i D. Vitezić, "Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market", Croatian medical journal, vol. 57, br. 6, str. 582-590, Prosinac 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:097911. [Citirano: 17.10.2019.]